CYP cynata therapeutics limited

Ann: Grant Award to Fund Study of Cynata MSCs in Heart Disease, page-42

  1. 13,050 Posts.
    lightbulb Created with Sketch. 788
    philby: "....shareholders need is Cmyerus with an SI type CEO... instead of wondering how much lower these SPs will go and how much more B/S we have to put up with from highly paid non performing boards."

    NOT sure what exactly "an SI type CEO is" (if it should refer to MSB - I am not interested in that company). ALL that CYP needs is a decently qualified CEO with good/great exposure to both the USA and JAPAN and start acting in the best interest of CYP share-holders (and not just the ones that are held by that "non performing board"). Purely just IMO, of course.

    I seriously do wonder IF there will ever be a change for the better here or not.

    wasa

    PS: Have mentally already written off my CYP shares as being worthless. So perhaps I shall one day be positively surprised. Time will tell.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
17.0¢
Change
-0.005(2.86%)
Mkt cap ! $38.41M
Open High Low Value Volume
17.5¢ 17.5¢ 17.0¢ $42.82K 247.5K

Buyers (Bids)

No. Vol. Price($)
4 141820 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
17.5¢ 58088 1
View Market Depth
Last trade - 14.00pm 07/08/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.